NewGenIvf Group Limited - Class A Ordinary Shares (NIVF)
1.7700
+0.5200 (41.60%)
NewGenIvf Group Limited is a biotechnology company focused on providing innovative solutions and services in the field of reproductive health and fertility
The company specializes in advanced in vitro fertilization (IVF) technologies and offers a range of services to assist individuals and couples in their journey to conceive. Through its state-of-the-art laboratories and clinical expertise, NewGenIvf Group is dedicated to improving patient outcomes and enhancing the overall experience of assisted reproduction, while also engaging in research and development to advance fertility treatments.
Wondering how the US markets performed one hour before the close of the markets on Wednesday? Discover the movers and shakers of today's session in our comprehensive analysis.
BANGKOK, March 03, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQNIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, announced that it has entered into a strategic collaboration agreement with BOBCARE FERTILITY GROUP LLC (“BOBCARE”) to jointly develop fertility services in the Kyrgyzstan market.
BANGKOK, Feb. 28, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQNIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced that it has received a written notice (the “Compliance Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) dated February 27, 2025, informing the Company that it has regained compliance with the minimum bid price requirement set forth under the Nasdaq Listing Rule 5450(a)(1) (the “Minimum Bid Price Requirement”).
As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
BANGKOK, Feb. 21, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQNIVF) (“NewGen” or the “Company”) today issued a clarification that, in the press release titled “NewGen Receives Continued Nasdaq Listing Approval and Announces New Business Development Director” issued on February 20, 2025, the Company did not intend to imply that it has already achieved compliance with the Nasdaq Capital Market’s $2.5 million minimum stockholders’ equity requirement (the “Equity Rule”). However, during its 1st quarter to date, certain NewGen debtholders converted $2.3 million of debt to equity and the Company has drawn down approximately $4.3 million from its Equity Line of Credit with White Lion Capital. Therefore, the Company believes it has in excess of $2.5 million in stockholders’ equity as of this date. The Company is awaiting confirmation from Nasdaq that it has evidenced compliance with the Equity Rule. However, there can be no assurance that Nasdaq will determine that the Company has regained compliance with the Nasdaq continued listing rules.
As the US market prepares to open on Wednesday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.
Looking for insights into the US markets one hour before the close of the markets on Tuesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Stay up-to-date with the latest market trends in the middle of the day on Tuesday. Explore the top gainers and losers during today's session in our detailed report.
Let's have a look at what is happening on the US markets one hour before the close of the markets on Thursday. Below you can find the top gainers and losers in today's session.
